The Latest in Follicular Lymphoma

FDA approves idelalisib for CLL, SLL and FL

July 24, 2014

Follicular Lymphoma

FDA approves idelalisib for three leukemia and lymphoma indications

July 23, 2014

Follicular Lymphoma

Combo appears safe and active in CLL, NHL

July 23, 2014

Follicular Lymphoma

Survival differences in blood cancers across Europe

July 14, 2014

Follicular Lymphoma

Novel agent shows promising activity in heavily pretreated NHL

June 11, 2014

Follicular Lymphoma

PET-CT accurately predicts survival of follicular lymphoma patients

June 9, 2014

Follicular Lymphoma

Agricultural chemicals and the risk of NHL

May 8, 2014

Follicular Lymphoma

Younger men with goiter at higher risk for thyroid cancers

April 10, 2014

Follicular Lymphoma

EC approves SC formulation of rituximab

March 31, 2014

Follicular Lymphoma

Vorinostat demonstrates antitumor activity in FL

March 26, 2014

Follicular Lymphoma

Anticancer drugs might promote lymphoma

March 25, 2014

Follicular Lymphoma

Idelalisib more effective in CLL, iNHL than MCL

March 11, 2014

Follicular Lymphoma

RIT can improve transplant outcomes in NHL, CLL

March 7, 2014

Follicular Lymphoma

Team identifies mutations that may drive FL

January 11, 2014

Follicular Lymphoma

Immune microenvironment linked to prognosis of follicular lymphoma

August 6, 2013

Follicular Lymphoma